Orthopedic devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Bone cement and casting materials are used to fix bone fractures or as a complement to other devices in procedures such as joint reconstruction and trauma fixation. Bone cement is a fixing material used to fill in spaces between an orthopedic prosthesis and the bone stock. GlobalData uses proprietary data and analytics to provide a comprehensive report on the bone cement devices market, including market shares of different players within Mexico. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Mexico Bone Cement Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the bone cement market in Mexico was Stryker followed by Zimmer Biomet and DePuy Synthes.

Bone cement helps restore functionality, provides elasticity to the zone between the prosthesis and the bone stock and maintains the mechanical stability of the prosthesis. Bone cement is composed of two components: PMMA (Polymethyl methacrylate) amorphous powder and MMA (methyl methacrylate) liquid stabilizer. This category includes both antibiotic and nonantibiotic bone cement. The use of antibiotic-loaded bone cements allows for high concentrations of antibiotics to be administered to the local areas surrounding the implant, protecting it from germs and preventing infection. Nonantibiotic bone cement is used to fixate artificial joints to the bone and fill non-union fractures.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the bone cement devices market within Mexico was expected to be over $6m in 2022.

For the latest complete market share analysis of bone cement device market in Mexico, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.